BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Denator AB Obtains 12 Million SEK in Financing Round


11/29/2010 11:50:46 AM

Gothenburg, Sweden – Denator AB today announced that it has completed the fifth round of financing, raising a total of 12 million SEK The new shares have been subscribed by existing investors including T-bolaget, Wikow Ventures AB, SGP Group & Servisen Holding AB as well as new private investors. The financing round will strengthen Denator’s position in the protein research market by significantly increasing marketing and sales activities globally as well as focusing the product portfolio development for key markets.

Olof Sköld, CEO at Denator says: “We are very pleased to have secured this financing round which will be put towards an ambitious growth plan with new product launches next year. This funding is an important milestone in the commercial development of Denator and it will enable the company to continue its expansion."

About Denator

Denator develops and sells products that stabilize biological tissues and fluids from the moment of sampling. Stabilization and standardization of sampling processes upstream significantly enhances the quality of data obtained from analytical techniques used downstream. In proteomic and peptidomic investigations, enhanced data quality increases the reliability of data interpretation and can reveal novel proteins and peptides that would be lost or undetectable when using conventional preparation techniques. Based upon the company’s proprietary heat- inactivation technology platform, Denator is developing solutions that enable scientists to stop sample degradation instantly and maintain the stability of sample components throughout the analytical workflow. Established in 2004, Denator is headquartered at the Biotech Center in Gothenburg, Sweden. For more information visit: www.denator.com or contact:

Olof Sköld CEO Denator AB E-mail: olof@denator.com Tel.: +46 31 41 28 91 Fax.: +46 31 41 28 40


Read at BioSpace.com


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->